drug

obeldesivir

1 story · latest Jun 30, 2026

Status: Investigational
Code: GS-5245
Trials: 1 registered trial in coverage

Relationships

Developed by Gilead Sciences

Timeline

Gilead's Phase 2 obeldesivir RSV trial terminated by sponsor; results posted

Jun 30Trial updateGilead Sciences obeldesivir

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.